Structure/functional studies previously reported showed that in and non-aromatic (guanidinium) cations which differ in lipoa series of simple organic cations in which the charge is delophilicity by addition of single alkyl groups were used to better calized, an aromatic ring and a minimal degree of lipophilicity study MDR.
H-octylpyridinium, the simple aromatic cation which has been shown to be to these agents. Furthermore, it was found that the resistance preferentially toxic to MDR؊ as compared to MDR؉ cells, ratio between MDR+/MDR− to the alkylpyridiniums increased uptake studies to determine whether resistance correlated with uptake differences between these two cell types. We also decreased drug accumulation were not available. Here, utilizpresent data which demonstrate that other organic cations which contain aromatic rings, a minimal degree of lipophilicity ing radioactive analogs of a select number of these simple 
MDR− cells was studied.
we find that human cells which express p-gp MDR, have similar Moreover, since previous cytotoxicity studies with these requirements for recognition of these simple compounds. In simple compounds were done in murine cell lines, the quesfact, the sensitivity profiles of these compounds closely correlate between murine and human cell lines. It was also found tion of whether human MDR+ cells had similar requirements that none of the series of simple organic compounds tested for recognition of these agents was addressed in the present showed modulatory activity in MDR؉ cells, as assayed by studies. Additionally, we also used these simple compounds 1 Thus, for this group of compounds chemical charge with concomitant reversal of resistance to these agents. 5 The appeared to play a role in p-gp-mediated MDR recognition.
human MDR+ cell line was a gift from Dr Victor Ling, Ontario It was also shown that anthracyclines with reduced or no Cancer Institute, Toronto, Ontario, Canada and was generated charge are accumulated more equally in sensitive-and multiby stepwise exposure of the parental CEM MDR− cell line drug-resistant cell variants. (Table 1) . Utilizing the human cell lines, CEM and 40 × 10 6 /ml, placed in a beaker with 2 ml of normal media CEM/VBL, which have been shown to be MDR− and MDR+, and magnetically stirred at 37°C in 5% CO 2 . The appropriate respectively, 6 we found that with continuous exposure to radioactive analog was added and incubated with the cells for guanidiniums and pyridiniums varying in lipophilicity the for-30 min. To a microcentrifuge tube layered with 25% sucrose mer compounds were not selectively toxic in these cells (s.g. 1.10) on the bottom (100 l) and 20% sucrose at the top (Table 1) . This correlates to what we had previously found (100 l) in blue dextran, 200 l of cells were gently added.
with the eight guanidinium homologs tested in the murine The cells were centrifuged at 15 000 r.p.m. immediately upon MDR+ and MDR− cell lines. 3 Correspondingly, the ID 50 for being placed in the tube. Sixty microliters of the top solution octylpyridinium was higher in this human MDR+ cell line than were removed from the solution, (labeled sample A), added in its MDR− cell counterpart as was found for the murine cell to 4 ml scintillation solution and read in a liquid scintillation lines. 3 With dodecylpyridinium which has a log P value counter. The rest of the fluid was removed and the cell pellet greater than that of octylpyridinium the resistance ratio was washed twice with cold isotonic solution. One hundred between MDR− and MDR+ was even higher. Moreover, the microliter of 10% HClO 4 was added to the washed pellet organic cation, triphenylmethyl phosphonium, with a log P which was centrifuged for 5 min at 15 000 r.p.m. Sixty microvalue of 1.20 when tested in both the murine and human cell liters of the cell pellet fluid (labeled sample B) were placed in lines also showed a high ratio of resistance. 4 ml of scintillation fluid and counted. In order to standardize When the human MDR+ cells were co-treated with verapameasurement of different radioactive analogs used intracellumil each of the ID 50 s to Rho 123, triphenylmethyl phoslar drug accumulation was calculated as a ratio as follows:
phonium, dodecylpyridinium and octylpyridinium decreased drug accumulation = (c.p.m. sample B/(c.p.m. sample A) × 2.
respectively, while the ID 50 to the guanidinium homologs remained unaffected (data not shown). This correlates with the results we reported for the response of murine MDR+ and Assay of MDR modulation MDR− cell lines to these compounds when co-treated with verapamil. 3 Table 1 illustrates that the MDR− and MDR+ Previously we have shown that MDR+ Friend leukemic cells murine and human cell lines show very similar cytotoxicity are cross-resistant to Rho 123. 4 Since this compound is fluorprofiles to the series of simple cationic compounds used in escent and enters/exits the cell rapidly it has become a quick these studies as well as to triphenylmethyl phosphonium and and easy screen for determining whether a cell has the MDR Rho 123. phenotype. Using a fluorescence microscope, cells are examined after they have been treated with 10 g/ml of Rho 123 for 15 min, rinsed in and placed in Rho 123-free medium. Those cells expressing the MDR+ p−gp-mediated phenotype Differential accumulation of alkylpyridiniums and will show either less brightly stained mitochondria than equivguanidiniums in MDR+ and MDR− cells alent MDR− cells or no visibly fluorescent mitochondria at all. In addition, verapamil has been shown to modulate this phenomenon 5 therefore a cell that is MDR+ will retain Rho With 1 h exposure to 3 H-octylpyridinium, the MDR+ rodent cell line ARN 15 accumulated 3.4 times less than its parental 123 in its mitochondria in the presence of 10 M verapamil for a substantial period of time after Rho 123 has been rinsed MDR− counterpart, FLC. In contrast, 3 H-pyridinium accumulated equivalently in both cell types. To determine further off. In order to test other compounds for their MDR modulation potency, MDR+ cells were loaded with 10 g/ml Rho whether the marked increased cytotoxicity we found with the organic cation triphenylmethyl phosphonium in MDR− vs 123 for 15 min in the presence or absence of the test modulator (10 M) and rinsed free of Rho 123. In the case where MDR+ cells correlated with increased drug accumulation in the former cell type, cells were incubated with 3 H triphenyl the test compound was coincubated with Rho 123 the same concentration of the test compound was maintained in the phosphonium and drug uptake was evaluated. The results showed greater than 46 times accumulation of this compound Rho 123-free rinse solution (Eagle's minimal essential medium supplemented with 10% fetal bovine serum). If the test comin MDR− vs MDR+ cells (Table 2) . In comparison about nine times more Rho 123 is found in these same MDR− vs MDR+ pound modulates MDR then the mitochondria remain as brightly stained as parental MDR− cells (FLC) whereas if it cells lines. The latter result was obtained from studies directly measuring the amount of Rho 123 intracellularly using HPLC does not, the cell does not retain the dye as well as MDR− cells, or not at all, in which case the mitochondria are not as described previously. Since we have shown that MDR+ cells do not recognize the entire series of cationic guanidiniums but do recogmethyl phosphonium while the accumulation ratio was higher for the latter compound, these differences may be explained nize pyridiniums with alkyl chains Ͼ4, it was surprising to find that neither of these two series of compounds could by the short incubation times for accumulation studies vs the longer times necessary to assay growth inhibition as well as modulate the retention of Rho 123 in MDR+ cells (Table 3) . Bay K8644, a calcium agonist, and reserpine, a calcium antagby the differences that may occur in their mechanisms for inhibiting growth. Clearly however, the fact that 3 H-guanidinonist, showed MDR modulatory activity when tested for increased Rho 123 retention in MDR+ cells (Table 3) .
ium which demonstrates equipotent toxicity in MDR+ and MDR− cells 3 showed no selective accumulation when tested in both cell types confirms the fact that guanidiniums are not recognized by the p-gp MDR pump. Thus, interpretation of Discussion our previous cytotoxicity data with these simple compounds which suggested that an aromatic ring and a certain degree The number of compounds reported to be recognized by cells expressing the MDR phenotype continues to increase. 4,9-13 of lipophilicity are necessary for their recognition by MDR is supported by the uptake data presented here. Most of these compounds are complex in nature and contain many structural differences.
4,9-13 Thus, the use of a series of Furthermore, it is interesting to note that Rho 123 and triphenylmethyl phosphonium which are much more complex simple cationic compounds which differ in lipophilicity by stepwise addition of alkyl groups offered an advantage in compounds than the pyridiniums we have shown to be recognized by MDR+ cells, have in common with these compounds studying the chemical requirements for MDR recognition. 3 Our results here with decreased accumulation of the radioat least one aromatic moiety and lipophilicity Ͼ log P−1. The log P for Rho 123 is 2.73 while that for triphenyl methyl phosactive analogs of octylpyridinium and triphenylmethyl phosphonium in MDR+ vs MDR− cells as well as with Rho 123, phonium is 1.20 as determined by partition coefficient assays previously described. 3 Our data therefore suggest, that in gencorrelates with their reported reduced toxicity in these same MDR+ as compared to MDR− cell lines as shown here and eral, compounds that are recognized by MDR contain at least one aromatic ring and have a partition coefficient greater than reported previously. 3 Although the resistance ratio for Rho 123 was found to be somewhat higher than for triphenyllog P −1.
